Rückkehr aus den Tropen und Subtropen: Risiko der Kolonisation mit ESBL-Bildnern

Jan Walter; Christoph Lübbert

doi:10.1055/a-0992-3762

Krankenhaushygiene up2date, Table of Contents

Krankenhaushygiene up2date 2020; 15(01): 63-74
DOI: 10.1055/a-0992-3762

Infektiologie

Rückkehr aus den Tropen und Subtropen: Risiko der Kolonisation mit ESBL-Bildnern

Jan Walter

,

Christoph Lübbert

Subject Editor: Wissenschaftlich verantwortlich gemäß Zertifizierungsbestimmungen für diesen Beitrag ist Dr. med. Tim Eckmanns, Berlin.

Abstract

All articles of this category

Insbesondere Enterobakterien sind durch den Erwerb und die Verbreitung von Beta-Laktamasen mit erweitertem Spektrum („extended spectrum beta-lactamase“, ESBL), die Resistenzen gegen die meisten Beta-Laktam-Antibiotika verleihen, zunehmend unempfindlich gegen die meisten verfügbaren Erstlinien-Antibiotika geworden. ESBL-produzierende Enterobakterien haben inzwischen breite Bevölkerungsschichten erreicht, was nicht zuletzt durch die zunehmende Zahl an Fernreisen bedingt ist.

Full Text

References

Literatur
1 UNWTO. International tourist arrivals reach 1.4 billion two years ahead of forecasts. Im Internet: https://www.unwto.org/global/press-release/2019-01-21/international-tourist-arrivals-reach-14-billion-two-years-ahead-forecasts
2 Doi Y, Iovleva A, Bonomo RA. The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world. J Travel Med 2017; 24: S44-51
3 Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med 2017; 24: S29-34
4 Woerther PL, Burdet C, Chachaty E. et al. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-758
5 Ny S, Kozlov R, Dumpis U. et al. Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia. Eur J Clin Microbiol Infect Dis 2018; 37: 2347-2354
6 Tängdén T, Cars O, Melhus A. et al. Foreign travel is a major risk factor forcolonization with Escherichia coli producing CTX-M-type extended-spectrumbeta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3548-3564
7 Ruppé E, Andremont A, Armand-Lefèvre L. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update. Travel Med Infect Dis 2018; 21: 28-35
8 Kantele A, Lääveri T, Mero S. et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis 2015; 60: 837-846
9 Kantele A, Mero S, Kirveskari J. et al. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study. Travel Med Infect Dis 2017; 16: 23-30
10 Kantele A, Mero S, Kirveskari J. et al. Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelersʼ Diarrhea. Emerg Infect Dis 2016; 22: 117-120
11 Lübbert C, Straube L, Stein C. et al. Colonization with extended spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol 2015; 305: 148-156
12 Barreto Miranda I, Ignatius R, Pfüller R. et al. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia. J Travel Med 2016; 23: tav024
13 Arcilla MS, van Hattem JM, Haverkate MR. et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis 2017; 17: 78-85
14 Khawaja T, Kirveskari J, Johansson S. et al. Patients hospitalized abroad as importers of multiresistant bacteria – a cross-sectional study. Clin Microbiol Infect 2017; 23: 673.e1-8
15 Wendt S, Böhm P, Jonas D. et al. How are travelers colonized with antimicrobial-resistant bacteria?. J Travel Med 2019; pii: taz068 [Epub ahead of print]
16 Frost I, Van Boeckel TP, Pires J. et al. Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel. J Travel Med 2019; pii: taz036 [Epub ahead of print]
17 Kumarasamy KK, Toleman MA, Walsh TR. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602
18 Lübbert C, Baars C, Dayakar A. et al. Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended spectrum beta-lactamase and carbapenemase-producing pathogens. Infection 2017; 45: 479-491
19 Meurs L, Lempp F, Lippmann N. et al. Intestinal colonization with extended-spectrum β-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016–2017). Travel Med Infect Dis 2019; 101521 [Epub ahead of print]
20 Razazi K, Derde LP, Verachten M. et al. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012; 38: 1769-778
21 Liu M, Li M, Wu L. et al. Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU. Medicine (Baltimore) 2018; 97: e12445
22 Prevel R, Boyer A, MʼZali F. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review. Crit Care 2019; 23: 170
23 Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI) Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsblatt 2012; 55: 1311-1354